What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Schizophrenia
His main research concerns Internal medicine, Endocrinology, Psychiatry, Body mass index and Genetics.
Helmut Remschmidt combines subjects such as Antipsychotic, Bulimia nervosa and Anorexia nervosa with his study of Internal medicine.
His Anorexia nervosa research is multidisciplinary, incorporating perspectives in Eating disorders, Plasma concentration and Emaciation.
His Endocrinology research integrates issues from Mutation, Missense mutation and Polymorphism.
His research investigates the link between Psychiatry and topics such as Age of onset that cross with problems in Comorbidity.
Helmut Remschmidt interconnects Anorexia nervosa, Demography, Pediatrics and Anthropometry in the investigation of issues within Body mass index.
His most cited work include:
- Several Mutations in the Melanocortin-4 Receptor Gene Including a Nonsense and a Frameshift Mutation Associated with Dominantly Inherited Obesity in Humans (405 citations)
- Rates of psychiatric disorders in a clinical study group of adolescents with extreme obesity and in obese adolescents ascertained via a population based study (298 citations)
- Auditory processing and dyslexia: evidence for a specific speech processing deficit (245 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Psychiatry, Internal medicine, Child and adolescent psychiatry, Endocrinology and Genetics.
His Psychiatry research includes themes of Pediatrics and Clinical psychology.
His Internal medicine research is multidisciplinary, incorporating elements of Clozapine, Polymorphism and Anorexia nervosa.
His research in Clozapine intersects with topics in Risperidone and Olanzapine.
His Endocrinology study frequently draws connections between adjacent fields such as Mutation.
Helmut Remschmidt usually deals with Genetics and limits it to topics linked to Dyslexia and Spelling, Cognitive psychology, Developmental psychology and Communication disorder.
He most often published in these fields:
- Psychiatry (30.15%)
- Internal medicine (16.14%)
- Child and adolescent psychiatry (14.65%)
What were the highlights of his more recent work (between 2007-2020)?
- Psychiatry (30.15%)
- Autism (5.10%)
- Child and adolescent psychiatry (14.65%)
In recent papers he was focusing on the following fields of study:
Psychiatry, Autism, Child and adolescent psychiatry, Genetics and Developmental psychology are his primary areas of study.
His research investigates the connection with Psychiatry and areas like Clinical psychology which intersect with concerns in Schizophrenia.
His Autism research focuses on Theory of mind and how it relates to Prefrontal cortex and Empathy.
His studies in Child and adolescent psychiatry integrate themes in fields like Medical education and Psychoanalysis.
His Genetics study frequently draws connections between related disciplines such as Dyslexia.
Helmut Remschmidt has researched Olanzapine in several fields, including Body mass index, Risperidone, Clozapine and Weight gain.
Between 2007 and 2020, his most popular works were:
- Dysfunctions in brain networks supporting empathy: An fMRI study in adults with autism spectrum disorders (133 citations)
- Evidence for the involvement of genetic variation in the oxytocin receptor gene (OXTR) in the etiology of autistic disorders on high-functioning level. (132 citations)
- Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course. (117 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Schizophrenia
Helmut Remschmidt mainly focuses on Autism, Genetics, Dyslexia, Psychiatry and Developmental psychology.
His studies deal with areas such as Theory of mind and Neuroscience as well as Autism.
His study in Dyslexia is interdisciplinary in nature, drawing from both Developmental genes, Cognition, Association and Behavioural genetics.
His Psychiatry research incorporates themes from Health care and Clinical psychology.
His Olanzapine study incorporates themes from Body mass index, Internal medicine and Dose Modification.
Helmut Remschmidt works mostly in the field of Body mass index, limiting it down to concerns involving Risperidone and, occasionally, Pediatrics, Antipsychotic, Twin study and Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
